Briggs Morrison - 21 Jun 2023 Form 4 Insider Report for Werewolf Therapeutics, Inc. (HOWL)

Role
Director
Signature
/s/ Jonathan Owen, Attorney-in-fact
Issuer symbol
HOWL
Transactions as of
21 Jun 2023
Net transactions value
$0
Form type
4
Filing time
23 Jun 2023, 17:07:47 UTC
Previous filing
20 Jun 2023
Next filing
11 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOWL Stock Option (right to buy) Award $0 +13,200 $0.000000 13,200 21 Jun 2023 Common Stock 13,200 $2.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on June 21, 2023. The shares underlying the option vest in full on the earlier of the first anniversary of the grant date and the next annual meeting of stockholders following the grant date, subject to the reporting person's continued service as a director.